News Search Results
Aug 22, 2024, 10:00 ET Lilly to participate in Morgan Stanley 22nd Annual Global Healthcare Conference
life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 22, 2024, 09:45 ET Eventide Announces Hire of I-hung Shih, PhD as Managing Director and Portfolio Manager
Dr. Shih brings a wealth of experience to the firm, particularly in the biotechnology sector, further enhancing Eventide's healthcare investment capabilities. Prior to joining Eventide, Dr. Shih was Co-Head of the Biotech Private
More news about: Eventide
Aug 22, 2024, 09:15 ET James Baumgartner, Ph.D., Named CEO of Keystone Symposia, Effective July 15, 2024
Jamie Baumgartner brings over 20 years of experience in the biotechnology and pharmaceutical sectors and is renowned for his strategic vision and scientific expertise. His career highlights include guiding hundreds of
More news about: Keystone Symposia
Aug 22, 2024, 09:00 ET Stem Cell Therapy developers I Peace and iCamuno Biotherapeutics Start Natural Killer Cell Trial for Ovarian Cancer
hopeful that our iNK cells will be a valuable weapon in the battle against ovarian cancer." I Peace, inc. I Peace is a biotechnology company harnessing the power of iPSCs to develop cell therapies for a range of diseases. The company's proprietary GMP-compliant iPSC platform allows
More news about: I Peace, Inc.; iCamuno Biotherapeutics
Aug 22, 2024, 09:00 ET Neuvivo Announces Mark Henderson, PhD, as Vice President of Manufacturing to Support Technical Operations for Investigational ALS Treatment
Henderson brings over 25 years of experience in pharmaceutical facility operations, quality assurance and manufacturing. Working across both global biotechnology companies and a private, clinical-stage startup, he has held leadership roles in early-stage manufacturing and process development for well-established
More news about: Neuvivo, Inc.
Aug 22, 2024, 09:00 ET A Decade of Dedication: Society for Science Announces 100 Educators in the 10th Year of the Advocate Program with $326,000 in Support
who will become trailblazers in diverse and emerging fields, from addressing global challenges in climate science to pioneering innovations in biotechnology.
More news about: Society for Science
Aug 22, 2024, 08:33 ET BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Aug 22, 2024, 08:32 ET NeuroXT and BIDMC Join Forces to Revolutionize Alzheimer's Treatment with AI
Aug. 22, 2024 /PRNewswire/ -- In a groundbreaking move that could transform Alzheimer's treatment, NeuroXT, a leading biotechnology startup, has partnered with Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital affiliated with Harvard Medical
More news about: NeuroXT
Aug 22, 2024, 07:34 ET Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt® technology to generate antibodies to a high-value target
STOCKHOLM, Aug. 22, 2024 /PRNewswire/ -- Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce that they have entered into a research collaboration agreement
More news about: Oblique Therapeutics AB
Aug 22, 2024, 07:30 ET First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity
complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange Commission. Palatin
More news about: Palatin Technologies, Inc.
Aug 22, 2024, 07:28 ET Oblique Therapeutics has entered a research collaboration agreement with Eli Lilly and Company to apply the AbiProt® technology to generate antibodies to a high-value target
STOCKHOLM, Aug. 22, 2024 /PRNewswire/ -- Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce that they have entered into a research collaboration agreement
More news about: Oblique Therapeutics AB
Aug 22, 2024, 05:10 ET Leqembi® (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain
LinkedIn. 6. About Biogen Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient's lives and to create value for shareholders and our communities.
More news about: Eisai Co., Ltd.
Aug 22, 2024, 04:00 ET Agricultural Microbial Market to Reach $27.7 Billion, Globally, by 2033 at 14.7% CAGR: Allied Market Research
adoption of innovative microbial products for crop improvement and environmental management. These countries are at the forefront of microbial biotechnology, with research institutions and companies investing in the development of tailored microbial inoculants for specific crops and environmental conditions.
More news about: Allied Market Research
Aug 22, 2024, 02:57 ET MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2024
million.Significant events during the quarter In April it was announced that Medivir's partner Vetbiolix, a veterinary biotechnology company based in France, reported positive results from a proof-of-concept clinical trial in canine periodontitis
More news about: Medivir
Aug 21, 2024, 21:30 ET Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares
Aug. 21, 2024 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today that it has entered into a definitive agreement
More news about: Virax Biolabs
Aug 21, 2024, 14:58 ET The STAR Consortium Announces a Major Milestone in Crohn's Disease Intestinal Strictures Imaging
consolidates and shares knowledge of Crohn's disease strictures with leading academic research institutions across the globe, and pharmaceutical and biotechnology partner organizations. "At Helmsley, we are committed to supporting research that builds standards and biomarkers for Crohn's disease, which
More news about: The Leona M. and Harry B. Helmsley Charitable Trust
Aug 21, 2024, 13:19 ET AI-Driven Cybersecurity Solutions: Innovations Shaping the Future of Data Protection
developing solutions in AI infrastructure. As part of their strategies, Avant has been seriously exploring additional technologies in the biotechnology and healthcare sectors, recently
More news about: USA News Group
Aug 21, 2024, 12:00 ET Complement Inhibitors Market is Predicted to Exhibit Remarkable Growth During the Study Period (2020-2034) | DelveInsight
authorities provides incentives such as market exclusivity, further fueling market growth. Technological advancements and innovations in biotechnology have also played a pivotal role in shaping the complement inhibitors market. The advent of monoclonal antibodies, recombinant proteins, and small
More news about: DelveInsight Business Research, LLP
Aug 21, 2024, 11:30 ET BCMA-Targeted Therapies Market to Witness Upsurge in Growth During the Study Period (2020-2034) | DelveInsight
products, and the key multiple myeloma companies, including Janssen, Pharmacyclics, Novartis, Incyte Corporation, Gracell Biotechnology, SpringWorks Therapeutics, Sana Biotechnology, Cytovia Therapeutics, Pfizer, MorphoSys, Biokine Therapeutics, Arcellx, Rapa Therapeutics, iTeos Therapeutics, Sorrento
More news about: DelveInsight Business Research, LLP
Aug 21, 2024, 09:30 ET Emerson Ventures Invests in Symmera
in 1995 and based in Boulder, Colorado, Boulder Ventures invests in high-potential information technology and biotechnology companies. For more information, visit
More news about: Emerson
Aug 21, 2024, 09:20 ET QurAlis to Participate in Upcoming Investor and Industry Conferences in September
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of amyotrophic lateral
More news about: QurAlis
Aug 21, 2024, 08:30 ET BioMarin Announces New R&D and Business Development Leadership
her many contributions to BioMarin – and to the patients we serve." About BioMarin Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root
More news about: BioMarin Pharmaceutical Inc.
Aug 21, 2024, 08:00 ET BioIVT Acquires ZenBio Inc.: Supporting Advancements in Drug Discovery and Cosmetics
scientific expertise and flexibility to meet researchers' needs. Both BioIVT and ZenBio share a vision of providing top-quality biospecimens and biotechnology services to support scientific discovery and innovation. "Our collaboration with BioIVT has always been driven by a shared commitment to
More news about: BioIVT
Aug 21, 2024, 08:00 ET Dovetail Genomics and Goenomics GmbH Announce Strategic Partnership to Enhance Genome Annotation Services
state-of-the-art solutions that enhance the accuracy and completeness of genome annotations, supporting research in genetics, molecular biology, and biotechnology. For more information on Goenomics, its technology, and service offerings, visit
More news about: Dovetail Genomics
Aug 21, 2024, 05:45 ET Biodegradable Polymers Market to Reach $55.2 Billion, Globally, by 2033 at 21.5% CAGR: Allied Market Research
The global biodegradable polymers market is experiencing growth due to several factors such as advances in material science and biotechnology, which are leading to the development of new biodegradable polymers with improved properties, opening up new possibilities for applications in various
More news about: Allied Market Research